Comparative study of efficacy and safety of microneedling versus combination of microneedling and topical autologous platelet rich plasma versus 30% glycolic acid peels in melasma

Dr Surabhi Dayal0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

研究概览

暂无简介。

•Patients of melasma of epidermal variety (differentiated by Woodâ??s lamp examination) with MASI more than 10 who have not taken treatment for melasma for last 4 weeks will be included in the study.

•1. Pregnant and lactating women.
•2. Patient with hypersensitivity to formulation used in the study.
•3. Patient on any topical and systemic concurrent therapy that can cause facial
•melanosis in last 4 weeks.
•4. Patient with active or recurrent herpes simplex infection, facial warts and
•molluscum contagiosum.
•5. Patient with history of or evidence of hypertrophic scar or keloid formation.
•6. Women on oral contraceptives and hormonal replacement therapy.
•7. Patient with history of photosensitivity.
•8. Patient having active dermatoses of atopic, seborrheic or other eczematous
•9. Patient on medications such as oral or topical retinoids, 5 Fluorouracil,
•10. History of corticosteroid therapy in last 4 weeks.
•11. History of bleeding disorders or on anticoagulant medications
•(warfarin,heparin,aspirin)
•12. Severe systemic illness or malignancy
•13. Patient with history of diabetes, collagen vascular disease, skin cancer or solar
•14. Patient having unrealistic expectations
•15. Uncooperative patients

发起方

Dr Surabhi Dayal